Found 0 matching trials
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin PHASE3 This phase III trial compares cetuxumab to chemotherapy, carboplatin and pa...
Show More Location
Tower Cancer Research Foundation
Learn More & Join Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial PHASE2 This ComboMATCH patient screening trial is the gateway to a coordinated set...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tumors EARLY_PHASE1 This clinical trial evaluates the safety and effectiveness of spatiotempora...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia PHASE2 This phase II trial studies how well pirtobrutinib and venetoclax work in t...
Show More Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Learn More & Join Trial
A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma PHASE2 This phase II trial studies olaparib and temozolomide in treating patients ...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Learn More & Join Trial
Testing BVD-523FB (Ulixertinib) as Potentially Targeted Treatment in Cancers With Genetic Changes (MATCH - Subprotocol Z1L) PHASE2 This phase II MATCH treatment trial tests how well BVD-523FB (ulixertinib) ...
Show More Status
Active Not Recruiting
Location
ECOG-ACRIN Cancer Research Group
Learn More & Join Trial
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma PHASE2 This phase II/III trial tests the safety, side effects, and best dose of th...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial PHASE2 This phase II ComboMATCH treatment trial compares selumetinib plus olaparib...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors PHASE2 This phase II trial studies how well olaparib and ceralasertib (AZD6738) wo...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
The Feasibility and Effect of PACUTS on Health Promotion for Stroke Wheelchair User in Long-term Care Institution NA Most of the residents in long-term care institution were wheelchair users, ...
Show More Location
Department of Occupational Therapy
Learn More & Join Trial